IMPORTANCE Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease in which microglia play a significant and active role. Recently, a rare missense variant (p.R47H) in the microglial activating gene TREM2 was found to increase the risk of several neurodegenerative diseases, including Alzheimer disease. Whether the p.R47H variant is a risk factor for ALS is not known.
A myotrophic lateral sclerosis (ALS) is a fatal disease caused by the progressive degeneration of upper and lower motor neurons. Activated microglia in the vicinity of degenerating neurons are a long-recognized pathologic feature of ALS, 1 but whether such activation is a beneficial response or injurious contributor to the disease process remains unclear. In fact, the answer may be both-mouse model data show that microglia express both neuroprotective and neurotoxic factors simultaneously 2 and may transition from a neuroprotective phenotype at symptom onset to become more neurotoxic later in the disease course. 3 There are many signaling pathways governing microglial phenotype, including a complex formed by TREM2 (OMIM 605086) and TYROBP (OMIM 604142), also known as DAP12. 4 Simultaneous activation of TREM2/TYROBP results in a potentially neuroprotective microglial state, with improved phagocytosis of apoptotic cellular debris and downregulation of inflammatory cytokines. 5 The importance of signaling through TREM2/TYROBP is made clear by the fact that recessive mutations in either gene cause early-onset frontotemporallike dementia, either in isolation 6 The genotype call rate was 99.7% in both cases and controls, resulting in 920 ALS and 1848 controls for comparison. The p.R47H carriers were validated by Sanger sequencing. Fiftyfive percent of the sporadic ALS cases were men, and mean (SD) age at the time of DNA collection was 61.0 (11.6) years; the control cohort included 44% men aged 68 (13.6) years. An additional control group of 25 023 individuals of European or European American descent was collated from published studies ( Table 1 ) and from the unrelated European Americans genotyped by whole-exome sequencing as part of the National Heart, Lung, and Blood Institute's Exome Sequencing Project. 18 Icelandic controls were not included given the isolation of the population and significantly higher minor allele frequency at rs75932628.
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TREM2 Expression Analysis Expression in Human Lumbar Spinal Cord
Total RNA was extracted from snap-frozen transverse sections of lumbar spinal cord of 18 autopsied patients with ALS ( Table 2 ) and 12 controls without neurologic disease (miRNeasy kit; Qiagen). Extracted RNA was quantified, and 40 ng was used as input for the quantitative polymerase chain reaction testing (EXPRESS One-Step Superscript, universal, 11781-200; Invitrogen) with validated TaqMan assays for human TREM2 and 3 endogenous controls: glyceraldehyde-3-phosphate dehydrogenase, peptidylprolyl isomerase, and ribosomal protein, large, P0 (Applied Biosystems 4331182, 
Statistical Analysis
All statistics were computed using R, version 3.0.1 (R Foundation for Statistical Computing; http://www.R-project.org/) except as noted otherwise. Fisher exact test was used to compare proportions of p.R47H carriers in cases and controls.
Comparisons of TREM2 expression were conducted using unpaired t tests, and correlations between TREM2 expression and participants' characteristics were performed using Spearman correlations (continuous variables) or the Mann-Whitney (dichotomous variables) test. Logistic regression was performed in PLINK, 19 with age and sex as covariates, using cases and controls for whom these data were available (913 of 920 ALS patients and 1803 of 1848 controls). All tests were 2-tailed, with the significance level set at P = .01 to correct for multiple comparisons. confirming that TREM2 p.R47H is a risk factor for ALS. The TREM2 p.R47H carriers in our cohort showed no significant difference in age at symptom onset, site of first symptom, or survival compared with those who were not carriers. However, the rarity of the variant limited our power to detect such a difference. A larger cohort of p.R47H carriers with ALS will be required to definitively determine effects on disease characteristics.
Results
TREM2 p.R47H in Sporadic ALS
TREM2 Expression in Spinal Cords From Humans With ALS and SOD1
G93A Mice
We examined spinal cord expression of TREM2 in lumbar spinal cord sections from 18 patients with ALS and found a 2.8-fold upregulation compared with controls (P = 2.8×10 −4 ) (Figure, A) . Expression levels did not correlate with age at onset, site of symptom onset, or presence of a known diseasecausing mutation (Table 2) . However, the degree of upregulation showed a modest inverse correlation with disease survival that was not statistically significant after correction for multiple comparisons. Because markers of microglial activation are also upregulated in models of SOD1 ALS, 20 we evaluated Trem2 expression in SOD1 G93A transgenic mice and found a 13-fold increase compared with expression in nontransgenic littermates (P = 2.8×10 −9 ) (Figure, B) . 
Discussion
Our study demonstrates that a rare variant in TREM2 (p.R47H) more than doubles the risk of ALS. In addition to identifying a novel risk factor for ALS, this finding provides, to our knowledge, the first link between genetic variation and microglial activation in ALS pathogenesis. This is important in light of a recent study 21 demonstrating that higher degrees of microglial activation on pathological examination were correlated with both the degree of upper motor neuron symptoms and more rapid disease progression. Interestingly, our evaluation of TREM2 expression in ALS spinal cord showed a similar trend, with higher levels of TREM2 correlating with shorter survival. Furthermore, our finding that 
Conclusions
We have shown that rare variants in TREM2 increase the risk for ALS and provide a genetic link to microglial activation in disease. This finding implicates the neuroinflammatory response as a target for further investigation in ALS pathogenesis and development of therapeutics. mice and 6 wild-type littermates, with normalization to an endogenous control. P values were calculated using a 2-tailed t test.
